Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Fuji
Federal Trade Commission
Merck
Citi
Deloitte
Cantor Fitzgerald
Express Scripts
Queensland Health
Boehringer Ingelheim

Generated: October 17, 2017

DrugPatentWatch Database Preview

TWINJECT 0.3 Drug Profile

« Back to Dashboard

Which patents cover Twinject 0.3, and when can generic versions of Twinject 0.3 launch?

Twinject 0.3 is a drug marketed by Impax Labs Inc and is included in one NDA. There are two patents protecting this drug.

This drug has forty-three patent family members in fifteen countries.

The generic ingredient in TWINJECT 0.3 is epinephrine. There are nineteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

Summary for Tradename: TWINJECT 0.3

US Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list9
Bulk Api Vendors: see list54
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TWINJECT 0.3 at DailyMed

Pharmacology for Tradename: TWINJECT 0.3

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc
TWINJECT 0.3
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020800-001May 30, 2003DISCNNoNo► Subscribe► SubscribeY ► Subscribe
Impax Labs Inc
TWINJECT 0.3
epinephrine
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS020800-001May 30, 2003DISCNNoNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: TWINJECT 0.3

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,905,352Kits containing medicine injection devices and containers► Subscribe
7,931,618Apparatuses and methods for injecting medicines to a desired depth► Subscribe
8,187,224Methods performed by medicine injection apparatuses► Subscribe
7,927,303Medicine injection devices and methods► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: TWINJECT 0.3

Country Document Number Estimated Expiration
China101850143► Subscribe
European Patent Office1904145► Subscribe
TaiwanI302841► Subscribe
South Africa200704516► Subscribe
Australia2005314401► Subscribe
Mexico2007006250► Subscribe
Japan4980237► Subscribe
Canada2589899► Subscribe
Mexico2007006251► Subscribe
Canada2585707► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Cerilliant
Baxter
McKesson
Colorcon
Citi
Mallinckrodt
Chubb
Express Scripts
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot